Novel Immunological Pathways for Mild to Moderate to severe asthma Qualitative Research by Dr. Amarjit Mishra (2)

1. Novel Immunological Pathways for Mild to Moderate to severe asthma: Qualitative Research by Dr. Amarjit Mishra Dr. Amarjit Mishra an Ex-assistant professor, Auburn University, is one of the eminent academics who has spent the last fifteen years working in the field of scientific research with a focus on mild, moderate as well as severe asthma. Dr. Amarjit Mishra earned a Ph.D.

2. STAGES OF ASTHMA Asthma is a chronic respiratory condition that can range in severity from mild to severe. The severity of asthma is typically determined based on the frequency and intensity of asthma symptoms, as well as the level of lung function impairment. Asthma can be differentiated on the basis of its severity into mild intermittent asthma, mild persistent asthma, moderate persistent asthma, and severe persistent asthma.

3. UNDERSTANDING ASTHMA FROM THE LENS OF DR. AMARJIT MISHRA Another research by Dr. Amarjit Mishra Auburn University and other research scientists have reported that dimethyl fumarate attenuates T helper type 2 (Th2) -mediated allergic airway inflate. motion by modulating dendritic cell function.

4. Dr. Amarjit Mishra has done many works, but his work on the significance of pharmacological targeting for the treatment of respiratory diseases based on the study of associated immunology is worth mentioning. In this direction, Dr. Mishra has been able to explore the possibility of pharmacological targeting of Th1/Th2/Th17 lung immune pathways through an extensive study of the immune pathways associated with the respiratory systems.

5. Hence, Dr. Amarjit Mishra, Auburn University has been doing tremendous work for the better understanding of novel Immunological Pathways for mild -to moderate- to severe asthma. Source:-https://gnblogger.com/2023/04/04/novel-immunological-pathways-for-mild-to-moderate-to-severe-asthma-qualitative-research-by-dr-amarjit-mishra/